ArticleFrontiers in oncology2021

Loss of IL-34 Expression Indicates Poor Prognosis in Patients With Lung Adenocarcinoma.

Zhendong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.